Search in:

Leukemia & Lymphoma Volume 45, 2004 - Issue 11

Views

CrossRef citations to date

Altmetric

Research Article

High Dose Chemotherapy with Thiotepa, Mitoxantrone and Carboplatin (TMJ) Followed by Autologous Stem Cell Support in 100 Consecutive Lymphoma Patients in a Single Centre: Analysis of Efficacy, Toxicity and Prognostic Factors

F Waheed Department of Hematology/Oncology New York Medical College and Zalmen A. Arlin Cancer Institute Valhalla NY USA

R Kancherla Department of Hematology/Oncology New York Medical College and Zalmen A. Arlin Cancer Institute Valhalla NY USA

K Seiter Department of Hematology/Oncology New York Medical College and Zalmen A. Arlin Cancer Institute Valhalla NY USA

D Liu Department of Hematology/Oncology New York Medical College and Zalmen A. Arlin Cancer Institute Valhalla NY USA

Z Qureshi Department of Hematology/Oncology New York Medical College and Zalmen A. Arlin Cancer Institute Valhalla NY USA

A Hoang Department of Hematology/Oncology New York Medical College and Zalmen A. Arlin Cancer Institute Valhalla NY USA

T Ahmed Department of Hematology/Oncology New York Medical College and Zalmen A. Arlin Cancer Institute Valhalla NY USA

show all

Pages 2253-2259 | Published online: 01 Jul 2009

Cite this article
https://doi.org/10.1080/10428190410001723250

References
Citations
Metrics
Reprints & Permissions

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (14)

N. Aghel, M. Lui, V. Wang, D. Khalaf, H. Mian, C. Hillis, I. Walker, B. Leber, J. H. Lipton, M. Aljama, K. Lepic, T. Berg, A. Garcia-Horton, J. Petropoulos, H. Masoom & D. P. Leong. (2023) Cardiovascular events among recipients of hematopoietic stem cell transplantation-A systematic review and meta-analysis. Bone Marrow Transplantation 58:5, pages 478-490.
Crossref

E Joffe, D Rosenberg, U Rozovski, C Perry, I Kirgner, S Trestman, O Gur, F Aviv, N Sarid, A Kolomansky, L Gepstein, Y Herishanu & E Naparstek. (2017) Replacing carmustine by thiotepa and cyclophosphamide for autologous stem cell transplantation in Hodgkin’s and non-Hodgkin’s B-cell lymphoma. Bone Marrow Transplantation 53:1, pages 29-33.
Crossref

N Shah, S Rauenzahn, L Veltri, S Wen, M Craig, M Hamadani, A S Kanate & A Cumpston. (2016) Long-term outcomes after thiotepa-based high-dose therapy (HDT) and autologous hematopoietic cell transplantation (auto-HCT) in non-Hodgkin lymphoma (NHL). Bone Marrow Transplantation 52:2, pages 321-322.
Crossref

L Sellner, A Boumendil, H Finel, S Choquet, G de Rosa, F Falzetti, R Scime, G Kobbe, F Ferrara, A Delmer, H Sayer, S Amorim, R Bouabdallah, J Finke, G Salles, I Yakoub-Agha, E Faber, E Nicolas-Virelizier, L Facchini, D Vallisa, E Zuffa, A Sureda & P Dreger. (2015) Thiotepa-based high-dose therapy for autologous stem cell transplantation in lymphoma: a retrospective study from the EBMT. Bone Marrow Transplantation 51:2, pages 212-218.
Crossref

Philip J. Bierman & Auayporn Nademanee. 2015. Thomas’ Hematopoietic Cell Transplantation. Thomas’ Hematopoietic Cell Transplantation 675 695 .

Ji‐Won Kim, Hyun Jung Lee, Hyeon Gyu Yi, Byung‐Su Kim, Soo‐Mee Bang, Jin Seok Kim, Inho Kim, Sung‐Soo Yoon, Jong Seok Lee, Chul Soo Kim, Seonyang Park & Byoung Kook Kim. (2012) Mitoxantrone, etoposide, cytarabine, and melphalan (NEAM) followed by autologous stem cell transplantation for patients with chemosensitive aggressive non‐Hodgkin lymphoma. American Journal of Hematology 87:5, pages 479-483.
Crossref

Denise M. Oliansky, Myron Czuczman, Richard I. Fisher, Frank D. Irwin, Hillard M. Lazarus, James Omel, Julie Vose, Steven N. Wolff, Roy B. Jones, Philip L. McCarthyJr.Jr. & Theresa Hahn. (2011) The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Diffuse Large B Cell Lymphoma: Update of the 2001 Evidence-Based Review. Biology of Blood and Marrow Transplantation 17:1, pages 20-47.e30.
Crossref

Suzanne Fanning & John W Sweetenham. 2009. Hematopoietic Stem Cell Transplantation in Clinical Practice. Hematopoietic Stem Cell Transplantation in Clinical Practice 267 277 .

M Mimeault, R Hauke & SK Batra. (2007) Recent Advances on the Molecular Mechanisms Involved in the Drug Resistance of Cancer Cells and Novel Targeting Therapies. Clinical Pharmacology & Therapeutics 83:5, pages 673-691.
Crossref

A.M. Evens, J.K. Altman, B.B. Mittal, N. Hou, A. Rademaker, D. Patton, L. Kaminer, S. Williams, S. Duffey, D. Variakojis, S. Singhal, M.S. Tallman, J. Mehta, J.N. Winter & L.I. Gordon. (2007) Phase I/II trial of total lymphoid irradiation and high-dose chemotherapy with autologous stem-cell transplantation for relapsed and refractory Hodgkin's lymphoma. Annals of Oncology 18:4, pages 679-688.
Crossref

J B Perz, C Giles, R Szydlo, D O'Shea, J Sanz, A Chaidos, S Wagner, J Davis, S Loaiza, D Marin, J Apperley, E Olavarria, A Rahemtulla, I Lampert, K Naresh, D Samson, D MacDonald & E J Kanfer. (2006) LACE-conditioned autologous stem cell transplantation for relapsed or refractory Hodgkin's lymphoma: treatment outcome and risk factor analysis in 67 patients from a single centre. Bone Marrow Transplantation 39:1, pages 41-47.
Crossref

M. Niang, M. Mělka, A. Stoklasová, J. Cerman & P. Tomšík. (2006) Evaluation of the antineoplastic activity of mitoxantrone–l-carnitine combination therapy on an experimental solid form of ehrlich tumour in mice. Pharmacological Research 54:6, pages 447-451.
Crossref

Felicetto Ferrara, Assunta Viola, Carolina Copia, Ettore Mariano Schiavone, Maria Celentano, Filiberto Pollio, Maria Rosaria D'Amico & Salvatore Palmieri. (2006) Therapeutic results in patients with relapsed diffuse large B cell Non‐Hodgkin's lymphoma achieving complete response only after autologous stem cell transplantation. Hematological Oncology 24:2, pages 73-77.
Crossref

. (2005) Current Awareness in Hematological Oncology. Hematological Oncology 22:4, pages 183-190.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

High Dose Chemotherapy with Thiotepa, Mitoxantrone and Carboplatin (TMJ) Followed by Autologous Stem Cell Support in 100 Consecutive Lymphoma Patients in a Single Centre: Analysis of Efficacy, Toxicity and Prognostic Factors

Articles from other publishers (14)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

High Dose Chemotherapy with Thiotepa, Mitoxantrone and Carboplatin (TMJ) Followed by Autologous Stem Cell Support in 100 Consecutive Lymphoma Patients in a Single Centre: Analysis of Efficacy, Toxicity and Prognostic Factors

Citations (14)

Articles from other publishers (14)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date